AzTrials
AzTrials

Abdominal PainNCT02536144

The Clinical Application of MCCES in Examination of Human Colon

A study testing Colonoscopy in people with Abdominal Pain and Diarrhea, run by Nanfang Hospital, Southern Medical University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is to determine the feasibility and safety of magnetic-controlled capsule endoscopy system in examination of human colon under the real time monitoring by colonoscopy in the clinical application. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Abdominal Pain, Diarrhea, Hematochezia
What is being tested?
Colonoscopy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteChina
Study dates
Aug 2015to Sep 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients who repeatedly have the symptom such as abdominal pain, diarrhea, hematochezia and so on, or
  • Patients who volunteer to the colonoscopy screening.

Who cannot join

  • Dysphagia or swallowing disorder,
  • Congestive heart failure,
  • Renal insufficiency,
  • Prior major abdominal surgery of the gastrointestinal tract,
  • Known or suspected bowel obstruction,
  • Presence of a cardiac pacemaker or other implanted electromedical devices,
  • Allergy or contraindication to the medications used in the study.

Trial locations and contacts

1 site in 1 country.

Hongxiang Gu, doctor contact

+86 15975625636

Redkind@126.com

Huiling Zheng, master contact

+86 15013113215

bywxling@163.com

China1 site, 1 recruiting
  • Nanfang Hospital of Southern Medical University

    Guangzhou, Guangdong, 510515

    huiling Zheng, master, +86 15013113215, bywxling@163.com

    Recruiting

Other trials in China

About this study

Official title: The Clinical Application of Magnetic-controlled Capsule Endoscopy System in Examination of Human Colon

This study is to determine the feasibility and safety of magnetic-controlled capsule endoscopy system in examination of human colon under the real time monitoring by colonoscopy in the clinical application.

Read the detailed description

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the Western world. The screening tests include flexible sigmoidoscopy, optical colonoscopy (OC), double-contrast barium enema , or CT colonography . Such screening can reduce CRC incidence and mortality but its effectiveness depends on its quality, ease of use, and patient adherence .Colon capsule endoscopy(CCE) is being actively evaluated as an emerging complementary or alternative procedure for evaluation of the colon. magnetic -controlled capsule endoscopy system is a new ingestible colon capsule robot provided by Chongqing Jinshan Science \& Technology. While Screening the colon, the capsule is drove by magnetic-manipulator outside the body, which means it can move from the cecum to anus step by step under the control of the doctor. However, there's little data report on this colon capsule robot system in clinical application. The investigators plan to conduct this prospective study to determine the feasibility and safety of magnetic-controlled capsule endoscopy system in examination of human colon under the real time monitoring by colonoscopy.

Being tested
magnetic-controlled capsule endoscopy system, Colonoscopy
Keywords
colon capsule, magnetic, maneuverability, colonoscopy
Medical subject headings
Abdominal Pain, Diarrhea, Gastrointestinal Hemorrhage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • magnetic-controlled capsule endoscopy systemProcedure or surgery

    1. A magnetic-controlled capsule endoscopy(MCCE) included camera,magnet,batter and high polymer material shell.
    2. The MCCE would be turned to sleeping mode capturing picture at a rate of 0.5 frame per second after being swallowed.
    3. While reaching cecum, the MCCE would be turned to a working mode capturing picture at a rate of 2 frame per second.
    4. The MCCE would be controlled by the Magnetic-manipulator out of body to finish the motion of e rotation, somersault, Bird's-eye view, worm's eye view from cecum to anus.
  • ColonoscopyProcedure or surgery

    Also called colonoscope

    1. Bowel preparation should be well done before the examination.
    2. A tube with illumination and camera system would insert into colon from anus.
    3. From the pictures captured by the camera ,the doctor would see the mucous of the colon.
Study groups in NCT02536144
Study groupRoleWhat they receive
MCCESExperimentalMagnetic -controlled capsule endoscopy system (MCCES) is a robot system that the capsule would be swallowed to observe the mucosa of the human alimentary canal especially the colon under the control of the magnetic-manipulator.
Receives: Procedure: magnetic-controlled capsule endoscopy system
ColonoscopyActive comparatorColonoscopy has now been in use for many years to visualize and diagnose abnormalities of the colon and it is the gold standard for detecting colorectal lesions.In this study,the additional utility of the colonoscopy is to monitor the movement of the Magnetic -controlled capsule endoscopy.
Receives: Procedure: Colonoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maneuverability

    The Maneuverability was defined as the rotation, somersault, Bird's-eye view, worm's eye view of the capsule, and completing any motion would gain 1 point, eventually ,4 point was good,2-3 point moderate,0-1point poor.

    Measured: From the MCCES examination began until the capsule excreted, an expected average of 24h

Secondary outcomes (5)
  1. Migration length of anus direction

    Migration length of anus direction was defined as how long was the distance the capsule controlled by the Magnetic-manipulator moved from cecum to anus in 25 minutes.

    Measured: From the MCCES examination began until the capsule excreted, an expected average of 24h

  2. The movement of mouth direction

    The movement of mouth direction was defined as if the capsule controlled by the Magnetic-manipulator could move from any point of the colon towards mouth direction.

    Measured: From the MCCES examination began until the capsule excreted, an expected average of 24h

  3. Nidus of colon

    From date of the examination until the date of pathological diagnosis, an expected average of 7 days

    Measured: During the procedure

  4. The level of cleanliness

    The cleanliness of the colon was graded as excellent (No more than small bits of adherent feces),good(Small amount of feces or dark fluid,but not enough to interfere with the examination ),fair(Enough feces or dark fluid present to preclude a completely reliable examination),poor(large amount of fecal residue).

    Measured: From the MCCES examination began until the capsule excreted, an expected average of 24h

  5. Procedure related complication

    Perforation, capsule retention, abdominal pain and so .etc.

    Measured: From the day of the examination until the follow up ended ,access up to 7 days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Aug 2015 (estimated)
  2. Study startAug 2015
  3. Primary completionSep 2015 (estimated)
  4. Study completionSep 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02536144
Sponsor's protocol ID
NFEK-2015-046
Status last verified
Aug 2015
First submitted
24 Aug 2015
Last updated
31 Aug 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Spada C, Hassan C, Ingrosso M, Repici A, Riccioni ME, Pennazio M, Pirozzi GA, Pagano N, Cesaro P, Spera G, Petruzziello L, Costamagna G. A new regimen of bowel preparation for PillCam colon capsule endoscopy: a pilot study. Dig Liver Dis. 2011 Apr;43(4):300-4. doi: 10.1016/j.dld.2010.10.005. Epub 2010 Nov 18.

    PubMed 21087902
  • Hagel AF, Gabele E, Raithel M, Hagel WH, Albrecht H, de Rossi TM, Singer C, Schneider T, Neurath MF, Farnbacher MJ. Colon capsule endoscopy: detection of colonic polyps compared with conventional colonoscopy and visualization of extracolonic pathologies. Can J Gastroenterol Hepatol. 2014 Feb;28(2):77-82. doi: 10.1155/2014/691785.

    PubMed 24501724
  • Gu H, Zheng H, Cui X, Huang Y, Jiang B. Maneuverability and safety of a magnetic-controlled capsule endoscopy system to examine the human colon under real-time monitoring by colonoscopy: a pilot study (with video). Gastrointest Endosc. 2017 Feb;85(2):438-443. doi: 10.1016/j.gie.2016.07.053. Epub 2016 Jul 29.

    PubMed 27480288

Questions about this trial

What is this clinical trial studying?

A study testing Colonoscopy in people with Abdominal Pain and Diarrhea, run by Nanfang Hospital, Southern Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Aug 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hongxiang Gu, doctor (+86 15975625636, Redkind@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maneuverability (time frame: From the MCCES examination began until the capsule excreted, an expected average of 24h). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02536144, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in